NXLIW logo

Nexalin Technology, Inc. Warrant


NXLIW: Nexalin Technology Inc design and develop innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy.


Show NXLIW Financials

Consumer Interest
SEC Filings

Recent trades of NXLIW by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by NXLIW's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of NXLIW in WallStreetBets Daily Discussion


Recent insights relating to NXLIW

CNBC Recommendations

Recent picks made for NXLIW stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in NXLIW

Corporate Flights

Flights by private jets registered to NXLIW